新加坡癌症科学研究所（CSI Singapore）于2008年10月15日正式成立。CSI新加坡旨在将新加坡定位为生物医学科学领域的全球领导者，致力于对癌症研究进行多方面和协调的方法，从基础癌症研究一直延伸到实验性治疗，从而改善癌症治疗。

CSI新加坡是一所最先进的大学研究机构，隶属于新加坡国立大学，并托管在新加坡国立大学。2008年，国家研究基金会和教育部授予了1.72亿美元的“卓越研究中心”赠款，这是新加坡仅有的五项赠款之一。CSI新加坡是世界知名科学家和新加坡著名人才发展计划的获奖者STaR调查员的家园，致力于彻底改变生物医学研究的格局，并将新加坡定位为全球领导者。其愿景是将CSI新加坡带到亚洲和世界癌症生物学和治疗的最前沿 - 成为亚洲主要的癌症研究中心，业务遍及全球。

研究所使命是通过招募优秀人才和提供世界一流的培训计划，为下一代研究创新者提供更好的癌症预防，诊断和治疗的研究平台。致力于调查癌症的发病机制，创造出更安全的诊断和治疗方法，挽救癌症病人的生命。

The Singapore Institute of Cancer Science (CSI Singapore) was officially established on 15 October 2008. CSI Singapore aims to position Singapore as a global leader in biomedical sciences, working on a multifaceted and coordinated approach to cancer research, extending from basic cancer research all the way to experimental treatments to improve cancer treatment.

CSI is one of the most advanced university research institutions in Singapore, affiliated with the National University of Singapore and hosted at the National University of Singapore. In 2008, the National Research Foundation and the Ministry of Education awarded a US$172 million Research Center of Excellence grant, one of only five grants in Singapore. Home to STaR investigators for world-renowned scientists and singapore's renowned talent development programme winners, CSI Singapore is committed to revolutionizing biomedical research and positioning Singapore as a global leader. Its vision is to bring CSI Singapore to the forefront of cancer biology and treatment in Asia and the world – to become a major cancer research centre in Asia with operations across the globe.

The Institute's mission is to provide a research platform for the next generation of research innovators to better cancer prevention, diagnosis and treatment by recruiting talented individuals and providing world-class training programs. Committed to investigating the pathogenesis of cancer, creating safer diagnosis and treatment methods, and saving the lives of cancer patients.